Lates News

Every Investment AI Express, Guojin Securities released a research report on April 27th, giving Aier Ophthalmology (300015.SZ) a "buy" rating. The reasons for the rating mainly include: 1) Non-recurring performance growth, maintaining excellent operating quality; 2) Driving growth with refraction and overseas business, digital strategy empowering high-quality development. (Daily Economic News)